Breakthrough in Immune Cell Expansion: Pluri Granted U.S Patent for New Method

HAIFA, Israel, April 08, 2024 (GLOBE NEWSWIRE) — Leading biotechnology company, Pluri Inc. (Nasdaq:PLUR) (TASE:PLUR) (“Pluri” or the “Company”), which transforms cells into solutions that promote global wellbeing and sustainability, today unveiled a novel method for expansion of immune cells using proprietary technology and announced it was granted a new U.S. patent titled, “System and Methods for Immune Cells Expansion and Activation in Large Scale.” Breakthrough in Immune Cell Expansion: Pluri Granted U.S Patent for New Method